- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2051-1426
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Intratumoral immunotherapy with the TLR7/8 agonist 3M-052 ; volume:1 ; number:1 ; day:7 ; month:11 ; year:2013 ; pages:1 ; date:11.2013
Journal for ImmunoTherapy of Cancer ; 1, Heft 1 (7.11.2013), 1, 11.2013
- Urheber
-
Smirnov, DV
- Beteiligte Personen und Organisationen
-
Zhao, G.
Beaurline, JM
Johnson, KE
Capecchi, JT
Harrison, LI
Tomai, MA
Elvecrog, JM
Klinman, DM
Vasilakos, JP
SpringerLink (Online service)
- DOI
-
10.1186/2051-1426-1-S1-P138
- URN
-
urn:nbn:de:1111-2016072652299
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:53 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Smirnov, DV
- Zhao, G.
- Beaurline, JM
- Johnson, KE
- Capecchi, JT
- Harrison, LI
- Tomai, MA
- Elvecrog, JM
- Klinman, DM
- Vasilakos, JP
- SpringerLink (Online service)
Ähnliche Objekte (12)
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
3M
3m Bleiwalzwerk
3M - Company
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
3M
3m Bleiwalzwerk
3M - Company
TLR7/8 agonist induces a post-entry SAMHD1-independent block to HIV-1 infection of monocytes
Deoxyguanosine is a TLR7 agonist
Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction
The TLR7 agonist Imiquimod promote the immunogenicity of msenchymal stem cells
Migrationsverhalten von NK-Zellen nach Stimulation mit dem TLR7-Agonisten Resiquimod
Lignin-chitosan-based biocomposite film for the localized delivery of TLR7 agonist imiquimod
T cell-independent eradication of experimental glioma by intravenous TLR7/8-agonist-loaded nanoparticles
Whole blood targeting and activation of monocytes with TLR7 agonist formulated in cationic liposomes
3M
3m Bleiwalzwerk
3M - Company